Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
Has NHS dm+d (dictionary of medicines and devices) controlled drug category |
Controlled drug category No Controlled Drug Status |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
Is a |
Virtual medicinal product pack |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
Is pack of |
Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection |
false |
Inferred relationship |
Existential restriction modifier |
|
|
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
Has active ingredient |
Beta-galactosidase |
false |
Inferred relationship |
Existential restriction modifier |
|
|
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
Has active ingredient |
Alpha-galactosidase |
false |
Inferred relationship |
Existential restriction modifier |
|
|
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
Has active ingredient |
Biological agent |
false |
Inferred relationship |
Existential restriction modifier |
|
|
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
VMP prescribing status (attribute) |
VMP valid as a prescribable product |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
VMP non-availability indicator |
Available |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
Powder for conventional release solution for injection |
false |
Inferred relationship |
Existential restriction modifier |
|
|
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
Has VMP |
Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
Has specific active ingredient |
Agalsidase beta |
false |
Inferred relationship |
Existential restriction modifier |
|
|
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
Has dispensed dose form |
Powder for infusion solution |
false |
Inferred relationship |
Existential restriction modifier |
|
|
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
Has specific active ingredient |
Agalsidase beta |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Agalsidase beta 5mg powder for solution for injection vials 1 vial |
Has dispensed dose form |
Powder for conventional release solution for infusion |
true |
Inferred relationship |
Existential restriction modifier |
|
|